 |
| |
Medicated skin care saw a current value terms increase of approaching 1.5% in 2009 to reach ¥149 billion. Growth was mainly driven by value added products such as switch OTC and more active ingredients. Products targeting specific consumers also performed well as seen in categories such as acne care. On the other hand, generic products and products with vague appeal were exposed to price competition, which was further caused by the new pharmaceutical law. Overall, Japanese consumers are open to...
This Medicated Skin Care Products in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Acne Treatments, Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Medicated Skin Care, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health industry;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
Medicated Skin Care in Japan
June 2010
List of Contents and Tables
Executive Summary
Consumer Healthcare Increases, Albeit at Lower Rate
Revised Pharmaceutical Law Impacts Consumer Healthcare Dynamics
Domestic Players Continue To Dominate Consumer Healthcare
Revised Pharmaceutical Law Impacts Consumer Healthcare Channels
Slower Growth Expected for Forecast Period
Key Trends and Developments
Revised Pharmaceutical Law Causes Controversy
Targeting the Active Ageing Society
Staying Fit Remains Priority Among Consumers
Recycling To Increase Sales
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
Consumer Healthcare Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 Consumer Healthcare Switches 2007-2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Daiichi Sankyo Healthcare Co Ltd
Strategic Direction
Key Facts
Summary 3 Daiichi Sankyo Healthcare Co Ltd: Key Facts
Summary 4 Daiichi Sankyo Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Daiichi Sankyo Healthcare Co Ltd: Competitive Position 2009
Eisai Co Ltd
Strategic Direction
Key Facts
Summary 6 Eisai Co Ltd: Key Facts
Summary 7 Eisai Co Ltd: Operational Indicators
Production
Competitive Positioning
Summary 8 Eisai Co Ltd: Competitive Position 2009
Hisamitsu Pharmaceutical Co Inc
Strategic Direction
Key Facts
Summary 9 Hisamitsu Pharmaceutical Co Inc: Key Facts
Summary 10 Hisamitsu Pharmaceutical Co Inc: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Hisamitsu Pharmaceutical Co Inc: Competitive Position 2009
Lion Corp
Strategic Direction
Key Facts
Summary 12 Lion Corp: Key Facts
Summary 13 Lion Corp: Operational Indicators
Production
Competitive Positioning
Summary 14 Lion Corp: Competitive Position 2009
Miki Corp
Strategic Direction
Key Facts
Summary 15 Miki Corp: Key Facts
Company Background
Production
Summary 16 Miki Corp: Production Statistics 2008
Competitive Positioning
Summary 17 Miki Corp: Competitive Position 2009
Rohto Pharmaceutical Co Ltd
Strategic Direction
Key Facts
Summary 18 Rohto Pharmaceutical Co Ltd: Key Facts
Summary 19 Rohto Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 20 Rohto Pharmaceutical Co Ltd: Competitive Position 2009
Sato Pharmaceutical Co Ltd
Strategic Direction
Key Facts
Summary 21 Sato Pharmaceutical Co Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 22 Sato Pharmaceutical Co Ltd: Competitive Position 2009
Ssp Co Ltd
Strategic Direction
Key Facts
Summary 23 SSP Co Ltd: Key Facts
Summary 24 SSP Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 25 SSP Co Ltd: Competitive Position 2009
Taisho Pharmaceutical Co Ltd
Strategic Direction
Key Facts
Summary 26 Taisho Pharmaceutical Co Ltd: Key Facts
Summary 27 Taisho Pharmaceutical Co Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 28 Taisho Pharmaceutical Co Ltd: Competitive Position 2009
Takeda Chemical Industries Ltd
Strategic Direction
Key Facts
Summary 29 Takeda Chemical Industries Ltd: Key Facts
Summary 30 Takeda Chemical Industries Ltd: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 31 Takeda Chemical Industries Ltd: Competitive Position 2009
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 12 Sales of Medicated Skin Care by Subsector: Value 2004-2009
Table 13 Sales of Medicated Skin Care by Subsector: % Value Growth 2004-2009
Table 14 Acne Treatments by Format: % Value Breakdown 2004-2009
Table 15 Medicated Skin Care Company Shares by Value 2005-2009
Table 16 Medicated Skin Care Brand Shares by Value 2006-2009
Table 17 Acne Treatments Brand Shares by Value 2006-2009
Table 18 Hair Loss Treatments Brand Shares by Value 2006-2009
Table 19 Forecast Sales of Medicated Skin Care by Subsector: Value 2009-2014
Table 20 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2009-2014
Browse all Healthcare and Medical Market Research Reports
http://www.companiesandmarkets.com/healthcare-and-medical-market-research-reports-p77.aspx
Browse all Healthcare and Medical Company Profile Reports
http://www.companiesandmarkets.com/healthcare-and-medical-company-profiles-p104.aspx
Browse all Latest Market Research Reports
http://www.companiesandmarkets.com/market-reports-trends-and-industry-statistics-p9.aspx
About Us
Companiesandmarkets.com is a leading online business information aggregator with over 500,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com's online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest. Companiesandmarkets.com is focused on providing clients with exemplary customer service and a flexible approach to accessing business information. Our team have extensive expertise in the market research industry and are keen to provide clients advice on their research requirements and possible alternative sources of information; a model which provides clients a value for money solution to research.
Medicated Skin Care - Japan - Market Report: http://www.companiesandmarkets.com/r.ashx?id=729HJKGS2322768&prk=41a3d03f8adb1c7f320a3dcb581f197e
|
—
